(Circulation. 1997;95:1253-1259.)
© 1997 American Heart Association, Inc.
Articles |
Dissociation of Left Ventricular Hypertrophy, ß-Myosin Heavy Chain Gene Expression, and Myosin Isoform Switch in Rats After Ascending Aortic Stenosis
the Department of Physiology II (R.J.W., J.C.R.) and the Department of Physiology I (H.E., J.F.), University of Heidelberg (Germany), and the Department of Medicine (R.Z.), University of Chicago (Ill).
Correspondence to Dr Heimo Ehmke or Dr Rudolf J. Wiesner, Department of Physiology, University of Heidelberg, Im Neuenheimer Feld 326, 69120 Heidelberg, Germany. E-mail rudolf.wiesner@urz.uni-heidelberg.de or ehmke{at}novsrv1.pio1.uni-heidelberg.de
Background Reexpression of the fetal ß-myosin heavy chain (ß-MHC) gene was reported to be a marker for phenotypic reprogramming and cardiac hypertrophy in rats. Recent in vitro studies strongly suggested a role of angiotensin II for phenotypic reprogramming. In the present investigation, ß-MHC gene expression was studied in an experimental model of pressure-overload hypertrophy that is not associated with a concurrent activation of the circulating renin-angiotensin system.
Methods and Results Hypertrophy was induced in rats by ascending aortic banding (n=40). After 7 days, myosin contained 31% (P<.05) of the ß-MHC isoform in banded but <5% in sham-operated animals. However, no specific elevation of ß-MHC mRNA levels was found in banded animals. In contrast, hearts of rats with abdominal aortic banding displayed a marked increase in ß-MHC mRNA levels (3-fold to 5-fold, P<.05). Both the left ventricular weight and left ventricular peak systolic pressure were significantly elevated compared with sham-operated animals (abdominal aortic banding, +13% and 164±7 mm Hg; ascending aortic banding, +27% and 191±9 mm Hg). Plasma renin activity was elevated in rats with abdominal aortic banding (2.5-fold, P<.05) but not in rats with ascending aortic banding.
Conclusions The results of the present work do not support the concept that increased ß-MHC gene expression is a general "stable late marker" of myocardial hypertrophy in rats. Our results suggest that the stimulation of the renin-angiotensin system is crucial for the activation of the ß-MHC gene.
Key Words: angiotensin • blood pressure • hypertrophy • remodeling • stenosis
This article has been cited by other articles:
 |
|
 |
|
  M.-C. Battista, E. Calvo, A. Chorvatova, B. Comte, J. Corbeil, and M. Brochu Intra-uterine growth restriction and the programming of left ventricular remodelling in female rats J. Physiol., May 15, 2005; 565(1): 197 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Volk, P. J. Noble, M. Wagner, D. Noble, and H. Ehmke Ascending aortic stenosis selectively increases action potential-induced Ca2+ influx in epicardial myocytes of the rat left ventricle Exp Physiol, January 1, 2005; 90(1): 111 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-L. Tian, Y. M. Pinto, O. Costerousse, W. M. Franz, A. Lippoldt, S. Hoffmann, T. Unger, and M. Paul Over-expression of angiotensin converting enzyme-1 augments cardiac hypertrophy in transgenic rats Hum. Mol. Genet., July 15, 2004; 13(14): 1441 - 1450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gupta, V. Sueblinvong, J. Raman, V. Jeevanandam, and M. P. Gupta Single-stranded DNA-binding Proteins PUR{alpha} and PUR{beta} Bind to a Purine-rich Negative Regulatory Element of the {alpha}-Myosin Heavy Chain Gene and Control Transcriptional and Translational Regulation of the Gene Expression: IMPLICATIONS IN THE REPRESSION OF {alpha}-MYOSIN HEAVY CHAIN DURING HEART FAILURE J. Biol. Chem., November 7, 2003; 278(45): 44935 - 44948. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Indolfi, E. Di Lorenzo, C. Perrino, A. M. Stingone, A. Curcio, D. Torella, A. Cittadini, L. Cardone, C. Coppola, L. Cavuto, et al. Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor Simvastatin Prevents Cardiac Hypertrophy Induced by Pressure Overload and Inhibits p21ras Activation Circulation, October 15, 2002; 106(16): 2118 - 2124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. F Bueno, E. van Rooij, J. D Molkentin, P. A Doevendans, and L. J De Windt Calcineurin and hypertrophic heart disease: novel insights and remaining questions Cardiovasc Res, March 1, 2002; 53(4): 806 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. H. Wang, X.-J. Du, D. J. Autelitano, C. A. Milano, and E. A. Woodcock Adverse effects of constitutively active alpha 1B-adrenergic receptors after pressure overload in mouse hearts Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1079 - H1086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Hill, M. Karimi, W. Kutschke, R. L. Davisson, K. Zimmerman, Z. Wang, R. E. Kerber, and R. M. Weiss Cardiac Hypertrophy Is Not a Required Compensatory Response to Short-Term Pressure Overload Circulation, June 20, 2000; 101(24): 2863 - 2869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. W. Brooks, O. H. L. Bing, M. O. Boluyt, A. Malhotra, J. P. Morgan, N. Satoh, W. S. Colucci, and C. H. Conrad Altered Inotropic Responsiveness and Gene Expression of Hypertrophied Myocardium With Captopril Hypertension, June 1, 2000; 35(6): 1203 - 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Miyata, W. Minobe, M. R. Bristow, and L. A. Leinwand Myosin Heavy Chain Isoform Expression in the Failing and Nonfailing Human Heart Circ. Res., March 3, 2000; 86(4): 386 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nagatomo, B. A. Carabello, M. Hamawaki, S. Nemoto, T. Matsuo, and P. J. McDermott Translational mechanisms accelerate the rate of protein synthesis during canine pressure-overload hypertrophy Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2176 - H2184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Lartaud-Idjouadiene, A.-M. Lompre, P. Kieffer, T. Colas, and J. Atkinson Cardiac Consequences of Prolonged Exposure to an Isolated Increase in Aortic Stiffness Hypertension, July 1, 1999; 34(1): 63 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. Sugden Signaling in Myocardial Hypertrophy : Life After Calcineurin? Circ. Res., April 2, 1999; 84(6): 633 - 646. [Full Text] [PDF]
|
|
|
|
|
|
H. Ehmke, J. Faulhaber, K. Munter, M. Kirchengast, and R. J. Wiesner Chronic ETA Receptor Blockade Attenuates Cardiac Hypertrophy Independently of Blood Pressure Effects in Renovascular Hypertensive Rats Hypertension, April 1, 1999; 33(4): 954 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Müller, S. Nemoto, M. Laser, B. A. Carabello, D. R. Menick;, and J. D. Molkentin; Calcineurin Inhibition and Cardiac Hypertrophy Science, November 6, 1998; 282(5391): 1007a - 1007. [Full Text]
|
|
|
|
|
|
K. Harada, I. Komuro, I. Shiojima, D. Hayashi, S. Kudoh, T. Mizuno, K. Kijima, H. Matsubara, T. Sugaya, K. Murakami, et al. Pressure Overload Induces Cardiac Hypertrophy in Angiotensin II Type 1A Receptor Knockout Mice Circulation, May 19, 1998; 97(19): 1952 - 1959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Murat, C. Pellieux, H.-R. Brunner, and T. Pedrazzini Calcineurin Blockade Prevents Cardiac Mitogen-activated Protein Kinase Activation and Hypertrophy in Renovascular Hypertension J. Biol. Chem., December 22, 2000; 275(52): 40867 - 40873. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Moser, J. Faulhaber, R. J. Wiesner, and H. Ehmke Predominant activation of endothelin-dependent cardiac hypertrophy by norepinephrine in rat left ventricle Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1389 - R1394. [Abstract] [Full Text] [PDF]
|
|